Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: A follow-up study

Authors:

Abstract
No abstract available
Funding Information
  • Novartis Biosciences S.A (CFTY720DBR07T)